Tahamtan Ahmadi
Net worth: 2 M $ as of 31/12/2025
Profile
Tahamtan Ahmadi is Chief Medical Officer & Executive Vice President at Genmab A. He previously occupied the position of Head-Experimental Medicine & Member at Janssen-Cilag A. Dr. Ahmadi received a doctorate from Universität zu Köln and a doctorate from the University of Freiburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENMAB A/S 0.01% | 12/02/2025 | 4,862 ( 0.01% ) | 2 M $ | 31/12/2025 |
Latest news about Tahamtan Ahmadi
Tahamtan Ahmadi active positions
| Companies | Position | Start |
|---|---|---|
| GENMAB A/S | Chief Tech/Sci/R&D Officer | 01/02/2021 |
Former positions of Tahamtan Ahmadi
| Companies | Position | End |
|---|---|---|
Janssen-Cilag A/S (Denmark)
Janssen-Cilag A/S (Denmark) Medical DistributorsDistribution Services Distributes pharmaceuticals products | Corporate Officer/Principal | - |
Training of Tahamtan Ahmadi
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genmab A/S
Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen-Cilag A/S (Denmark)
Janssen-Cilag A/S (Denmark) Medical DistributorsDistribution Services Distributes pharmaceuticals products | Distribution Services |
- Stock Market
- Insiders
- Tahamtan Ahmadi
















